 | • レポートコード：QYR2104Z4191 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ノルカンタリジンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（植物医学、ホルモン、標的小分子薬、薬剤耐性代謝）、用途別市場規模（肝臓がん、食道がん、胃がん、心臓がん、脊柱後側弯症、肝臓肝炎＆肝硬変、B型肝炎ウイルス）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ノルカンタリジンの市場動向 ・企業の競争状況、市場シェア ・ノルカンタリジンの種類別市場規模（植物医学、ホルモン、標的小分子薬、薬剤耐性代謝） ・ノルカンタリジンの用途別市場規模（肝臓がん、食道がん、胃がん、心臓がん、脊柱後側弯症、肝臓肝炎＆肝硬変、B型肝炎ウイルス） ・ノルカンタリジンの北米市場規模2016-2027（アメリカ、カナダ） ・ノルカンタリジンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ノルカンタリジンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ノルカンタリジンの中南米市場規模2016-2027（メキシコ、ブラジル） ・ノルカンタリジンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pharmacia、Nippon Kayaku、Pfizer、MATRIX、Shanghai Zhaohui Pharmaceutical、Tongfang Pharmaceutical Group、Hainan Tongyong Tongmeng Pharmaceutical、Qilu Pharmaceutical、Jiangsu Hengrui Pharmaceutical、Hanhui Pharmaceutical、Huabei Pharmaceutical、Shandong Shanda Kangnuo Pharmaceutical、Beijing Wanhui Shuanghe Pharmaceutical、Yingzi Maishitong Pharmaceutical、Shandong Renhetang Pharmaceutical、Shandong Xinyi Pharmaceutical、Sinopharm、Guangdong Jianxin Pharmaceutical、Xi 'an Haixin Pharmaceutical） ・結論 |
Norcantharidin is a synthetic anticancer compound, that is, a derivative of cantharidin, which is the product of the main anticancer component of traditional Chinese medicine cantharidin by hydrolysis to dimethyl.
Market Analysis and Insights: Global Norcantharidin Market
The global Norcantharidin market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Norcantharidin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Norcantharidin market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Norcantharidin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Norcantharidin market.
Global Norcantharidin Scope and Market Size
Norcantharidin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Norcantharidin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Plant Medicine
Hormone
Target Small Molecule Drugs
Metabolism Of Drug Resistance
Segment by Application
Liver Cancer
Esophageal Cancer
Stomach Cancer
Cardia Cancer
Hypoleucosis
Hepatitis & Cirrhosis Of The Liver
Hepatitis B Virus
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pharmacia
Nippon Kayaku
Pfizer
MATRIX
Shanghai Zhaohui Pharmaceutical
Tongfang Pharmaceutical Group
Hainan Tongyong Tongmeng Pharmaceutical
Qilu Pharmaceutical
Jiangsu Hengrui Pharmaceutical
Hanhui Pharmaceutical
Huabei Pharmaceutical
Shandong Shanda Kangnuo Pharmaceutical
Beijing Wanhui Shuanghe Pharmaceutical
Yingzi Maishitong Pharmaceutical
Shandong Renhetang Pharmaceutical
Shandong Xinyi Pharmaceutical
Sinopharm
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Norcantharidin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Plant Medicine
1.2.3 Hormone
1.2.4 Target Small Molecule Drugs
1.2.5 Metabolism Of Drug Resistance
1.3 Market by Application
1.3.1 Global Norcantharidin Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Liver Cancer
1.3.3 Esophageal Cancer
1.3.4 Stomach Cancer
1.3.5 Cardia Cancer
1.3.6 Hypoleucosis
1.3.7 Hepatitis & Cirrhosis Of The Liver
1.3.8 Hepatitis B Virus
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Norcantharidin Market Perspective (2016-2027)
2.2 Norcantharidin Growth Trends by Regions
2.2.1 Norcantharidin Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Norcantharidin Historic Market Share by Regions (2016-2021)
2.2.3 Norcantharidin Forecasted Market Size by Regions (2022-2027)
2.3 Norcantharidin Industry Dynamic
2.3.1 Norcantharidin Market Trends
2.3.2 Norcantharidin Market Drivers
2.3.3 Norcantharidin Market Challenges
2.3.4 Norcantharidin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Norcantharidin Players by Revenue
3.1.1 Global Top Norcantharidin Players by Revenue (2016-2021)
3.1.2 Global Norcantharidin Revenue Market Share by Players (2016-2021)
3.2 Global Norcantharidin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Norcantharidin Revenue
3.4 Global Norcantharidin Market Concentration Ratio
3.4.1 Global Norcantharidin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Norcantharidin Revenue in 2020
3.5 Norcantharidin Key Players Head office and Area Served
3.6 Key Players Norcantharidin Product Solution and Service
3.7 Date of Enter into Norcantharidin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Norcantharidin Breakdown Data by Type
4.1 Global Norcantharidin Historic Market Size by Type (2016-2021)
4.2 Global Norcantharidin Forecasted Market Size by Type (2022-2027)
5 Norcantharidin Breakdown Data by Application
5.1 Global Norcantharidin Historic Market Size by Application (2016-2021)
5.2 Global Norcantharidin Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Norcantharidin Market Size (2016-2027)
6.2 North America Norcantharidin Market Size by Type
6.2.1 North America Norcantharidin Market Size by Type (2016-2021)
6.2.2 North America Norcantharidin Market Size by Type (2022-2027)
6.2.3 North America Norcantharidin Market Size by Type (2016-2027)
6.3 North America Norcantharidin Market Size by Application
6.3.1 North America Norcantharidin Market Size by Application (2016-2021)
6.3.2 North America Norcantharidin Market Size by Application (2022-2027)
6.3.3 North America Norcantharidin Market Size by Application (2016-2027)
6.4 North America Norcantharidin Market Size by Country
6.4.1 North America Norcantharidin Market Size by Country (2016-2021)
6.4.2 North America Norcantharidin Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Norcantharidin Market Size (2016-2027)
7.2 Europe Norcantharidin Market Size by Type
7.2.1 Europe Norcantharidin Market Size by Type (2016-2021)
7.2.2 Europe Norcantharidin Market Size by Type (2022-2027)
7.2.3 Europe Norcantharidin Market Size by Type (2016-2027)
7.3 Europe Norcantharidin Market Size by Application
7.3.1 Europe Norcantharidin Market Size by Application (2016-2021)
7.3.2 Europe Norcantharidin Market Size by Application (2022-2027)
7.3.3 Europe Norcantharidin Market Size by Application (2016-2027)
7.4 Europe Norcantharidin Market Size by Country
7.4.1 Europe Norcantharidin Market Size by Country (2016-2021)
7.4.2 Europe Norcantharidin Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Norcantharidin Market Size (2016-2027)
8.2 Asia-Pacific Norcantharidin Market Size by Type
8.2.1 Asia-Pacific Norcantharidin Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Norcantharidin Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Norcantharidin Market Size by Type (2016-2027)
8.3 Asia-Pacific Norcantharidin Market Size by Application
8.3.1 Asia-Pacific Norcantharidin Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Norcantharidin Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Norcantharidin Market Size by Application (2016-2027)
8.4 Asia-Pacific Norcantharidin Market Size by Region
8.4.1 Asia-Pacific Norcantharidin Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Norcantharidin Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Norcantharidin Market Size (2016-2027)
9.2 Latin America Norcantharidin Market Size by Type
9.2.1 Latin America Norcantharidin Market Size by Type (2016-2021)
9.2.2 Latin America Norcantharidin Market Size by Type (2022-2027)
9.2.3 Latin America Norcantharidin Market Size by Type (2016-2027)
9.3 Latin America Norcantharidin Market Size by Application
9.3.1 Latin America Norcantharidin Market Size by Application (2016-2021)
9.3.2 Latin America Norcantharidin Market Size by Application (2022-2027)
9.3.3 Latin America Norcantharidin Market Size by Application (2016-2027)
9.4 Latin America Norcantharidin Market Size by Country
9.4.1 Latin America Norcantharidin Market Size by Country (2016-2021)
9.4.2 Latin America Norcantharidin Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Norcantharidin Market Size (2016-2027)
10.2 Middle East & Africa Norcantharidin Market Size by Type
10.2.1 Middle East & Africa Norcantharidin Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Norcantharidin Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Norcantharidin Market Size by Type (2016-2027)
10.3 Middle East & Africa Norcantharidin Market Size by Application
10.3.1 Middle East & Africa Norcantharidin Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Norcantharidin Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Norcantharidin Market Size by Application (2016-2027)
10.4 Middle East & Africa Norcantharidin Market Size by Country
10.4.1 Middle East & Africa Norcantharidin Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Norcantharidin Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pharmacia
11.1.1 Pharmacia Company Details
11.1.2 Pharmacia Business Overview
11.1.3 Pharmacia Norcantharidin Introduction
11.1.4 Pharmacia Revenue in Norcantharidin Business (2016-2021)
11.1.5 Pharmacia Recent Development
11.2 Nippon Kayaku
11.2.1 Nippon Kayaku Company Details
11.2.2 Nippon Kayaku Business Overview
11.2.3 Nippon Kayaku Norcantharidin Introduction
11.2.4 Nippon Kayaku Revenue in Norcantharidin Business (2016-2021)
11.2.5 Nippon Kayaku Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Norcantharidin Introduction
11.3.4 Pfizer Revenue in Norcantharidin Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 MATRIX
11.4.1 MATRIX Company Details
11.4.2 MATRIX Business Overview
11.4.3 MATRIX Norcantharidin Introduction
11.4.4 MATRIX Revenue in Norcantharidin Business (2016-2021)
11.4.5 MATRIX Recent Development
11.5 Shanghai Zhaohui Pharmaceutical
11.5.1 Shanghai Zhaohui Pharmaceutical Company Details
11.5.2 Shanghai Zhaohui Pharmaceutical Business Overview
11.5.3 Shanghai Zhaohui Pharmaceutical Norcantharidin Introduction
11.5.4 Shanghai Zhaohui Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.5.5 Shanghai Zhaohui Pharmaceutical Recent Development
11.6 Tongfang Pharmaceutical Group
11.6.1 Tongfang Pharmaceutical Group Company Details
11.6.2 Tongfang Pharmaceutical Group Business Overview
11.6.3 Tongfang Pharmaceutical Group Norcantharidin Introduction
11.6.4 Tongfang Pharmaceutical Group Revenue in Norcantharidin Business (2016-2021)
11.6.5 Tongfang Pharmaceutical Group Recent Development
11.7 Hainan Tongyong Tongmeng Pharmaceutical
11.7.1 Hainan Tongyong Tongmeng Pharmaceutical Company Details
11.7.2 Hainan Tongyong Tongmeng Pharmaceutical Business Overview
11.7.3 Hainan Tongyong Tongmeng Pharmaceutical Norcantharidin Introduction
11.7.4 Hainan Tongyong Tongmeng Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.7.5 Hainan Tongyong Tongmeng Pharmaceutical Recent Development
11.8 Qilu Pharmaceutical
11.8.1 Qilu Pharmaceutical Company Details
11.8.2 Qilu Pharmaceutical Business Overview
11.8.3 Qilu Pharmaceutical Norcantharidin Introduction
11.8.4 Qilu Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.8.5 Qilu Pharmaceutical Recent Development
11.9 Jiangsu Hengrui Pharmaceutical
11.9.1 Jiangsu Hengrui Pharmaceutical Company Details
11.9.2 Jiangsu Hengrui Pharmaceutical Business Overview
11.9.3 Jiangsu Hengrui Pharmaceutical Norcantharidin Introduction
11.9.4 Jiangsu Hengrui Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.9.5 Jiangsu Hengrui Pharmaceutical Recent Development
11.10 Hanhui Pharmaceutical
11.10.1 Hanhui Pharmaceutical Company Details
11.10.2 Hanhui Pharmaceutical Business Overview
11.10.3 Hanhui Pharmaceutical Norcantharidin Introduction
11.10.4 Hanhui Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.10.5 Hanhui Pharmaceutical Recent Development
11.11 Huabei Pharmaceutical
11.11.1 Huabei Pharmaceutical Company Details
11.11.2 Huabei Pharmaceutical Business Overview
11.11.3 Huabei Pharmaceutical Norcantharidin Introduction
11.11.4 Huabei Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.11.5 Huabei Pharmaceutical Recent Development
11.12 Shandong Shanda Kangnuo Pharmaceutical
11.12.1 Shandong Shanda Kangnuo Pharmaceutical Company Details
11.12.2 Shandong Shanda Kangnuo Pharmaceutical Business Overview
11.12.3 Shandong Shanda Kangnuo Pharmaceutical Norcantharidin Introduction
11.12.4 Shandong Shanda Kangnuo Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.12.5 Shandong Shanda Kangnuo Pharmaceutical Recent Development
11.13 Beijing Wanhui Shuanghe Pharmaceutical
11.13.1 Beijing Wanhui Shuanghe Pharmaceutical Company Details
11.13.2 Beijing Wanhui Shuanghe Pharmaceutical Business Overview
11.13.3 Beijing Wanhui Shuanghe Pharmaceutical Norcantharidin Introduction
11.13.4 Beijing Wanhui Shuanghe Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.13.5 Beijing Wanhui Shuanghe Pharmaceutical Recent Development
11.14 Yingzi Maishitong Pharmaceutical
11.14.1 Yingzi Maishitong Pharmaceutical Company Details
11.14.2 Yingzi Maishitong Pharmaceutical Business Overview
11.14.3 Yingzi Maishitong Pharmaceutical Norcantharidin Introduction
11.14.4 Yingzi Maishitong Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.14.5 Yingzi Maishitong Pharmaceutical Recent Development
11.15 Shandong Renhetang Pharmaceutical
11.15.1 Shandong Renhetang Pharmaceutical Company Details
11.15.2 Shandong Renhetang Pharmaceutical Business Overview
11.15.3 Shandong Renhetang Pharmaceutical Norcantharidin Introduction
11.15.4 Shandong Renhetang Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.15.5 Shandong Renhetang Pharmaceutical Recent Development
11.16 Shandong Xinyi Pharmaceutical
11.16.1 Shandong Xinyi Pharmaceutical Company Details
11.16.2 Shandong Xinyi Pharmaceutical Business Overview
11.16.3 Shandong Xinyi Pharmaceutical Norcantharidin Introduction
11.16.4 Shandong Xinyi Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.16.5 Shandong Xinyi Pharmaceutical Recent Development
11.17 Sinopharm
11.17.1 Sinopharm Company Details
11.17.2 Sinopharm Business Overview
11.17.3 Sinopharm Norcantharidin Introduction
11.17.4 Sinopharm Revenue in Norcantharidin Business (2016-2021)
11.17.5 Sinopharm Recent Development
11.18 Guangdong Jianxin Pharmaceutical
11.18.1 Guangdong Jianxin Pharmaceutical Company Details
11.18.2 Guangdong Jianxin Pharmaceutical Business Overview
11.18.3 Guangdong Jianxin Pharmaceutical Norcantharidin Introduction
11.18.4 Guangdong Jianxin Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
11.18.5 Guangdong Jianxin Pharmaceutical Recent Development
11.18 Xi ‘an Haixin Pharmaceutical
.1 Xi ‘an Haixin Pharmaceutical Company Details
.2 Xi ‘an Haixin Pharmaceutical Business Overview
.3 Xi ‘an Haixin Pharmaceutical Norcantharidin Introduction
.4 Xi ‘an Haixin Pharmaceutical Revenue in Norcantharidin Business (2016-2021)
.5 Xi ‘an Haixin Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Norcantharidin Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Plant Medicine
Table 3. Key Players of Hormone
Table 4. Key Players of Target Small Molecule Drugs
Table 5. Key Players of Metabolism Of Drug Resistance
Table 6. Global Norcantharidin Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Norcantharidin Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Norcantharidin Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Norcantharidin Market Share by Regions (2016-2021)
Table 10. Global Norcantharidin Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Norcantharidin Market Share by Regions (2022-2027)
Table 12. Norcantharidin Market Trends
Table 13. Norcantharidin Market Drivers
Table 14. Norcantharidin Market Challenges
Table 15. Norcantharidin Market Restraints
Table 16. Global Norcantharidin Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Norcantharidin Market Share by Players (2016-2021)
Table 18. Global Top Norcantharidin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Norcantharidin as of 2020)
Table 19. Ranking of Global Top Norcantharidin Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Norcantharidin Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Norcantharidin Product Solution and Service
Table 23. Date of Enter into Norcantharidin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Norcantharidin Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Norcantharidin Revenue Market Share by Type (2016-2021)
Table 27. Global Norcantharidin Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Norcantharidin Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Norcantharidin Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Norcantharidin Revenue Market Share by Application (2016-2021)
Table 31. Global Norcantharidin Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Norcantharidin Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Norcantharidin Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Norcantharidin Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Norcantharidin Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Norcantharidin Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Norcantharidin Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Norcantharidin Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Norcantharidin Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Norcantharidin Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Norcantharidin Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Norcantharidin Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Norcantharidin Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Norcantharidin Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Norcantharidin Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Norcantharidin Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Norcantharidin Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Norcantharidin Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Norcantharidin Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Norcantharidin Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Norcantharidin Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Norcantharidin Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Norcantharidin Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Norcantharidin Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Norcantharidin Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Norcantharidin Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Norcantharidin Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Norcantharidin Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Norcantharidin Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Norcantharidin Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Norcantharidin Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Norcantharidin Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pharmacia Company Details
Table 64. Pharmacia Business Overview
Table 65. Pharmacia Norcantharidin Product
Table 66. Pharmacia Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 67. Pharmacia Recent Development
Table 68. Nippon Kayaku Company Details
Table 69. Nippon Kayaku Business Overview
Table 70. Nippon Kayaku Norcantharidin Product
Table 71. Nippon Kayaku Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 72. Nippon Kayaku Recent Development
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Norcantharidin Product
Table 76. Pfizer Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. MATRIX Company Details
Table 79. MATRIX Business Overview
Table 80. MATRIX Norcantharidin Product
Table 81. MATRIX Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 82. MATRIX Recent Development
Table 83. Shanghai Zhaohui Pharmaceutical Company Details
Table 84. Shanghai Zhaohui Pharmaceutical Business Overview
Table 85. Shanghai Zhaohui Pharmaceutical Norcantharidin Product
Table 86. Shanghai Zhaohui Pharmaceutical Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 87. Shanghai Zhaohui Pharmaceutical Recent Development
Table 88. Tongfang Pharmaceutical Group Company Details
Table 89. Tongfang Pharmaceutical Group Business Overview
Table 90. Tongfang Pharmaceutical Group Norcantharidin Product
Table 91. Tongfang Pharmaceutical Group Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 92. Tongfang Pharmaceutical Group Recent Development
Table 93. Hainan Tongyong Tongmeng Pharmaceutical Company Details
Table 94. Hainan Tongyong Tongmeng Pharmaceutical Business Overview
Table 95. Hainan Tongyong Tongmeng Pharmaceutical Norcantharidin Product
Table 96. Hainan Tongyong Tongmeng Pharmaceutical Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 97. Hainan Tongyong Tongmeng Pharmaceutical Recent Development
Table 98. Qilu Pharmaceutical Company Details
Table 99. Qilu Pharmaceutical Business Overview
Table 100. Qilu Pharmaceutical Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 101. Qilu Pharmaceutical Recent Development
Table 102. Jiangsu Hengrui Pharmaceutical Company Details
Table 103. Jiangsu Hengrui Pharmaceutical Business Overview
Table 104. Jiangsu Hengrui Pharmaceutical Norcantharidin Product
Table 105. Jiangsu Hengrui Pharmaceutical Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 106. Jiangsu Hengrui Pharmaceutical Recent Development
Table 107. Hanhui Pharmaceutical Company Details
Table 108. Hanhui Pharmaceutical Business Overview
Table 109. Hanhui Pharmaceutical Norcantharidin Product
Table 110. Hanhui Pharmaceutical Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 111. Hanhui Pharmaceutical Recent Development
Table 112. Huabei Pharmaceutical Company Details
Table 113. Huabei Pharmaceutical Business Overview
Table 114. Huabei Pharmaceutical Norcantharidin Product
Table 115. Huabei Pharmaceutical Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 116. Huabei Pharmaceutical Recent Development
Table 117. Shandong Shanda Kangnuo Pharmaceutical Company Details
Table 118. Shandong Shanda Kangnuo Pharmaceutical Business Overview
Table 119. Shandong Shanda Kangnuo Pharmaceutical Norcantharidin Product
Table 120. Shandong Shanda Kangnuo Pharmaceutical Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 121. Shandong Shanda Kangnuo Pharmaceutical Recent Development
Table 122. Beijing Wanhui Shuanghe Pharmaceutical Company Details
Table 123. Beijing Wanhui Shuanghe Pharmaceutical Business Overview
Table 124. Beijing Wanhui Shuanghe Pharmaceutical Norcantharidin Product
Table 125. Beijing Wanhui Shuanghe Pharmaceutical Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 126. Beijing Wanhui Shuanghe Pharmaceutical Recent Development
Table 127. Yingzi Maishitong Pharmaceutical Company Details
Table 128. Yingzi Maishitong Pharmaceutical Business Overview
Table 129. Yingzi Maishitong Pharmaceutical Norcantharidin Product
Table 130. Yingzi Maishitong Pharmaceutical Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 131. Yingzi Maishitong Pharmaceutical Recent Development
Table 132. Shandong Renhetang Pharmaceutical Company Details
Table 133. Shandong Renhetang Pharmaceutical Business Overview
Table 134. Shandong Renhetang Pharmaceutical Norcantharidin Product
Table 135. Shandong Renhetang Pharmaceutical Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 136. Shandong Renhetang Pharmaceutical Recent Development
Table 137. Shandong Xinyi Pharmaceutical Company Details
Table 138. Shandong Xinyi Pharmaceutical Business Overview
Table 139. Shandong Xinyi Pharmaceutical Norcantharidin Product
Table 140. Shandong Xinyi Pharmaceutical Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 141. Shandong Xinyi Pharmaceutical Recent Development
Table 142. Sinopharm Company Details
Table 143. Sinopharm Business Overview
Table 144. Sinopharm Norcantharidin Product
Table 145. Sinopharm Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 146. Sinopharm Recent Development
Table 147. Guangdong Jianxin Pharmaceutical Company Details
Table 148. Guangdong Jianxin Pharmaceutical Business Overview
Table 149. Guangdong Jianxin Pharmaceutical Norcantharidin Product
Table 150. Guangdong Jianxin Pharmaceutical Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 151. Guangdong Jianxin Pharmaceutical Recent Development
Table 152. Xi 'an Haixin Pharmaceutical Company Details
Table 153. Xi 'an Haixin Pharmaceutical Business Overview
Table 154. Xi 'an Haixin Pharmaceutical Norcantharidin Product
Table 155. Xi 'an Haixin Pharmaceutical Revenue in Norcantharidin Business (2016-2021) & (US$ Million)
Table 156. Xi 'an Haixin Pharmaceutical Recent Development
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Norcantharidin Market Share by Type: 2020 VS 2027
Figure 2. Plant Medicine Features
Figure 3. Hormone Features
Figure 4. Target Small Molecule Drugs Features
Figure 5. Metabolism Of Drug Resistance Features
Figure 6. Global Norcantharidin Market Share by Application: 2020 VS 2027
Figure 7. Liver Cancer Case Studies
Figure 8. Esophageal Cancer Case Studies
Figure 9. Stomach Cancer Case Studies
Figure 10. Cardia Cancer Case Studies
Figure 11. Hypoleucosis Case Studies
Figure 12. Hepatitis & Cirrhosis Of The Liver Case Studies
Figure 13. Hepatitis B Virus Case Studies
Figure 14. Norcantharidin Report Years Considered
Figure 15. Global Norcantharidin Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Norcantharidin Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Norcantharidin Market Share by Regions: 2020 VS 2027
Figure 18. Global Norcantharidin Market Share by Regions (2022-2027)
Figure 19. Global Norcantharidin Market Share by Players in 2020
Figure 20. Global Top Norcantharidin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Norcantharidin as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Norcantharidin Revenue in 2020
Figure 22. Global Norcantharidin Revenue Market Share by Type (2016-2021)
Figure 23. Global Norcantharidin Revenue Market Share by Type (2022-2027)
Figure 24. North America Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Norcantharidin Market Share by Type (2016-2027)
Figure 26. North America Norcantharidin Market Share by Application (2016-2027)
Figure 27. North America Norcantharidin Market Share by Country (2016-2027)
Figure 28. United States Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Norcantharidin Market Share by Type (2016-2027)
Figure 32. Europe Norcantharidin Market Share by Application (2016-2027)
Figure 33. Europe Norcantharidin Market Share by Country (2016-2027)
Figure 34. Germany Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Norcantharidin Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Norcantharidin Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Norcantharidin Market Share by Region (2016-2027)
Figure 44. China Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Norcantharidin Market Share by Type (2016-2027)
Figure 52. Latin America Norcantharidin Market Share by Application (2016-2027)
Figure 53. Latin America Norcantharidin Market Share by Country (2016-2027)
Figure 54. Mexico Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Norcantharidin Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Norcantharidin Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Norcantharidin Market Share by Country (2016-2027)
Figure 60. Turkey Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Norcantharidin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Pharmacia Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 64. Nippon Kayaku Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 66. MATRIX Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 67. Shanghai Zhaohui Pharmaceutical Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 68. Tongfang Pharmaceutical Group Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 69. Hainan Tongyong Tongmeng Pharmaceutical Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 70. Qilu Pharmaceutical Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 71. Jiangsu Hengrui Pharmaceutical Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 72. Hanhui Pharmaceutical Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 73. Huabei Pharmaceutical Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 74. Shandong Shanda Kangnuo Pharmaceutical Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 75. Beijing Wanhui Shuanghe Pharmaceutical Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 76. Yingzi Maishitong Pharmaceutical Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 77. Shandong Renhetang Pharmaceutical Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 78. Shandong Xinyi Pharmaceutical Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 79. Sinopharm Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 80. Guangdong Jianxin Pharmaceutical Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 81. Xi 'an Haixin Pharmaceutical Revenue Growth Rate in Norcantharidin Business (2016-2021)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
世界のノルカンタリジン市場規模・現状・予測（2021年-2027年） Norcantharidin is a synthetic anticancer compound, that is, a derivative of cantharidin, which is the product of the main anticancer component of traditional Chinese medicine cantharidin by hydrolysis to dimethyl. Market Analysis and Insights: Global Norcantharidin Market The global Norcantharidin m…- 世界の肝臓がん治療市場規模・現状・予測（2021年-2027年） Liver cancer, also known as hepatic cancer and primary hepatic cancer, is cancer that starts in the liver. Cancer which has spread from elsewhere to the liver, known as liver metastasis, is more common than that which starts in the liver. Symptoms of liver cancer may include a lump or pain in the ri…
- 世界の小分子標的がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targeted Cancer Therapy Market The global Small Molecule Targeted Cancer Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…
- 世界のプラチナベース抗がん剤市場規模・現状・予測（2021年-2027年） Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include ci…
- 世界の肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung Cancer Treatment Drugs are durgs used to cure lung cancer. In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing…